This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Bronchial thermoplasty for severe asthma

Authoring team

The aim of bronchial thermoplasty for severe asthma is to reduce airway smooth muscle mass, thereby decreasing the ability of the airways to constrict.

  • bronchial thermoplasty is usually performed with the patient under sedation or general anaesthesia.
    • a specially designed catheter is introduced into the bronchial tree
    • short pulses of radiofrequency energy are applied circumferentially to sequential portions of the airway wall, moving from distal (diameter > 3 mm) to proximal (main bronchi) at 5 mm intervals
    • treatment is usually delivered in 3 sessions with an interval of at least 3 weeks between each session. After the first treatment session, previously treated airways are evaluated by bronchoscopy before proceeding with further treatment

NICE have suggested that "..Evidence on the efficacy of bronchial thermoplasty for severe asthma shows some improvement in symptoms and quality of life, and reduced exacerbations and admission to hospital. Evidence on safety is adequate in the short and medium term. More evidence is required on the safety of the procedure in the long term. Therefore, this procedure should only be used with special arrangements for clinical governance, consent and audit or research.."

Reference:


Related pages

Create an account to add page annotations

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.